A Multicenter, Phase I, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Etirinotecan Pegol in Patients with Refractory Solid Tumors by JAMESON, Gayle S, HAMM, John T, HINSHAW, Loana, JOTTE, Robert, ROSEN, Lee S, HOCH, Ute, ELDON, Michael A, MEDVE, Robert, SCHROEDER, Katrina, WHITE, Erica, VON HOFF, Daniel D, WEISS, Glen J, ALEMANY, Carlos, ANTHONY, Stephen, BASCHE, Michele, RAMANATHAN, Ramesh K, BORAD, Mitesh J, TIBES, Raoul, COHN, Allen

Get full text